Emergent BioSolutions | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amarin USD -16755000 35.77M 2025-03
ANI Pharmaceuticals USD 26.19M 30.57M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Exact Sciences USD -96010000 780.34M 2025-03
Exelixis USD 186.86M 23.65M 2025-04
Glaxosmithkline GBP 702M 513M 2024-12
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Lonza CHF 430M 104M 2024-12
Merck USD 5.87B 1.57B 2025-03
Moderna USD -1050000000 196M 2025-03
Myriad Genetics USD -29000000 10M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Pacira USD 1.99M 22.71M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
PTC Therapeutics USD 970.22M 1.03B 2025-03
Sanofi EUR 2.28B 1.42B 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
United Therapeutics USD 382.8M 25.1M 2025-03


Emergent BioSolutions Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.